Emerging drugs for attention-deficit/hyperactivity disorder.
about
Pharmacological characterization of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1H-inden-2-yl]-2-propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulator.Psychopharmacology of ADHD in pediatrics: current advances and issues.Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro.
P2860
Emerging drugs for attention-deficit/hyperactivity disorder.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Emerging drugs for attention-deficit/hyperactivity disorder.
@en
type
label
Emerging drugs for attention-deficit/hyperactivity disorder.
@en
prefLabel
Emerging drugs for attention-deficit/hyperactivity disorder.
@en
P2860
P1476
Emerging drugs for attention-deficit/hyperactivity disorder.
@en
P2093
Richard H Weisler
P2860
P304
P356
10.1517/14728214.12.3.423
P407
P577
2007-09-01T00:00:00Z